Hengrui Medicine (SSE: 600276) has completed its first share buyback through centralized bidding today, repurchasing 335,000 A-shares for a total consideration of 14.5036 million yuan. The buyback price ranged between 43.58 yuan and 43.10 yuan per share, representing approximately 0.005% of the company's total share capital. This initial repurchase aligns with the company's previously announced plan to use self-owned funds for buybacks totaling between 1 billion and 2 billion yuan, designated for its employee stock ownership plan, with the program slated to run from August 19, 2026, through August 18, 2027.
Ankai Automobile (SSE: 000868) has surged for the fourth time in five trading sessions, prompting its major shareholder Anhui Province Investment Group Holdings Co., Ltd. to announce a planned reduction of up to 8.0246 million shares, or 0.85% of the company's total equity. The stake sale will be executed through centralized bidding during a 90-calendar-day window beginning 15 trading days after the disclosure date.
Guangqi Technology's wholly-owned subsidiary, Guangqi Advanced Technology, has inked batch production contracts worth a combined 907 million yuan with three clients. Under the agreements, the subsidiary will supply metamaterial structural products valued at 862 million yuan to one client, with delivery schedules determined by subsequent purchase orders, while the remaining two clients will receive products worth 45.2942 million yuan, with deliveries expected to conclude by the end of 2026. The cumulative contract value of 907 million yuan is anticipated to have a modest impact on 2026 operating results but is expected to contribute positively to 2027 performance.
Risk Warnings on Volatile Stocks
Changzhou Aohong Electronics Co.,Ltd. (SSE: 605058) has now logged five consecutive limit-up sessions. The company issued a statement clarifying that while the PCB industry faces multiple external headwinds, its Thailand production facility is unlikely to materially affect near-term financial results.
Buybacks and Shareholding Adjustments
Zhenlan Instrument's chairman has proposed a share buyback program ranging from 80 million to 160 million yuan. Meanwhile, Fujian Expressway's controlling shareholder intends to increase its stake by 130 million to 230 million yuan. Hengtong Co., Ltd.'s controlling shareholder has secured a 90 million yuan special loan commitment letter to support share purchases. On the selling side, Jiangshun Technology shareholders plan to offload up to 3% of shares, Chitianhua's shareholder Great Wall Company intends to reduce its position by no more than 3%, Huiyu Pharmaceutical's shareholder Huang Ganyi faces a passive reduction of up to 2.46%, and Yuanxiang New Materials' shareholder Huaxing Venture Capital plans to trim up to 1.22% of shares.
Major Contract Wins
China Ruilin has signed an overseas copper tailings leaching plant project contract worth approximately 3.378 billion yuan. Shanxi Construction has won a 1.05 billion yuan EPC contract for an energy storage power station. Zhejiang Construction Investment's subsidiary has secured a public housing development project in Hong Kong valued at roughly HK$1.5 billion. Additionally, Xianghe Industrial has inked a 178 million yuan sales agreement for railway fastener system components.